BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 6339859)

  • 1. Serotonin receptor changes after chronic antidepressant treatments: ligand binding, electrophysiological, and behavioral studies.
    Anderson JL
    Life Sci; 1983 Apr; 32(16):1791-801. PubMed ID: 6339859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiologically-identified serotonin receptors in the rat CNS. Effect of antidepressant treatment.
    de Montigny C; Blier P; Chaput Y
    Neuropharmacology; 1984 Dec; 23(12B):1511-20. PubMed ID: 6396527
    [No Abstract]   [Full Text] [Related]  

  • 3. The importance of brain serotonergic receptor mechanisms for the action of antidepressant drugs.
    Ogren SO; Fuxe K; Agnati L
    Pharmacopsychiatry; 1985 Mar; 18(2):209-13. PubMed ID: 3927330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressants and serotonergic neurotransmission: an integrative review.
    Willner P
    Psychopharmacology (Berl); 1985; 85(4):387-404. PubMed ID: 2410942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic antidepressant therapy and associated changes in central monoaminergic receptor functioning.
    Sugrue MF
    Pharmacol Ther; 1983; 21(1):1-33. PubMed ID: 6312466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presynaptic and postsynaptic modifications of the serotonin system by long-term administration of antidepressant treatments. An in vivo electrophysiologic study in the rat.
    Chaput Y; de Montigny C; Blier P
    Neuropsychopharmacology; 1991 Dec; 5(4):219-29. PubMed ID: 1839498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor sensitivity and the mechanism of action of antidepressant treatment. Implications for the etiology and therapy of depression.
    Charney DS; Menkes DB; Heninger GR
    Arch Gen Psychiatry; 1981 Oct; 38(10):1160-80. PubMed ID: 6271089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic properties of serotonergic agents and antidepressant drugs.
    Fuller RW
    J Clin Psychiatry; 1987 Mar; 48 Suppl():5-11. PubMed ID: 3493240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin receptor binding sites: is there pharmacological and clinical significance?
    Leysen J
    Med Biol; 1983 Jun; 61(3):139-43. PubMed ID: 6314066
    [No Abstract]   [Full Text] [Related]  

  • 10. Galanin receptor antagonists : a potential novel pharmacological treatment for mood disorders.
    Ogren SO; Kuteeva E; Hökfelt T; Kehr J
    CNS Drugs; 2006; 20(8):633-54. PubMed ID: 16863269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addition of lithium to chronic antidepressant treatment potentiates presynaptic serotonergic function without changes in serotonergic receptors in the rat cerebral cortex.
    Okamoto Y; Motohasi N; Hayakawa H; Muraoka M; Yamawaki S
    Neuropsychobiology; 1996; 33(1):17-20. PubMed ID: 8821370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for a role of 5-HT1C receptors in the antiserotonergic properties of some antidepressant drugs.
    Jenck F; Moreau JL; Mutel V; Martin JR; Haefely WE
    Eur J Pharmacol; 1993 Feb; 231(2):223-9. PubMed ID: 8453978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indorenate produces antidepressant-like actions in the rat forced swimming test via 5-HT1A receptors.
    Martínez-Mota L; Estrada-Camarena E; López-Rubalcava C
    Psychopharmacology (Berl); 2002 Dec; 165(1):60-6. PubMed ID: 12474119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies.
    Schechter LE; Bolaños FJ; Gozlan H; Lanfumey L; Haj-Dahmane S; Laporte AM; Fattaccini CM; Hamon M
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1335-47. PubMed ID: 1702155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antidepressant drugs and central monoaminergic receptors].
    Asakura M; Tsukamoto T
    Yakubutsu Seishin Kodo; 1985 Dec; 5(4):303-19. PubMed ID: 2870595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of serotonin and dopamine in the mechanism of action of novel antidepressant drugs: a review.
    Bonhomme N; Esposito E
    J Clin Psychopharmacol; 1998 Dec; 18(6):447-54. PubMed ID: 9864076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of 5-hydroxytryptamine-induced behavioral effects following chronic administration of antidepressant drugs.
    Jones RS
    Psychopharmacology (Berl); 1980; 69(3):307-11. PubMed ID: 6774372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisense inhibition of 5-hydroxytryptamine2a receptor induces an antidepressant-like effect in mice.
    Sibille E; Sarnyai Z; Benjamin D; Gal J; Baker H; Toth M
    Mol Pharmacol; 1997 Dec; 52(6):1056-63. PubMed ID: 9415715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of serotonin type 2 (5-HT2) and beta-adrenergic receptors in rat cerebral cortex following novel and classical antidepressant treatment.
    Lafaille F; Welner SA; Suranyi-Cadotte BE
    J Psychiatry Neurosci; 1991 Nov; 16(4):209-14. PubMed ID: 1664741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of chronic administration of antidepressant drugs on 5-HT2-mediated behavior in the rat following noradrenergic or serotonergic denervation.
    Eison AS; Yocca FD; Gianutsos G
    J Neural Transm Gen Sect; 1991; 84(1-2):19-32. PubMed ID: 1647168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.